Singular Genomics Systems Inc (OMIC)
0.3939
-0.02
(-4.95%)
USD |
NASDAQ |
Apr 24, 16:00
0.3939
0.00 (0.00%)
After-Hours: 20:00
Singular Genomics Systems Debt to Equity Ratio: 0.0497 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0497 |
| September 30, 2023 | 0.0511 |
| June 30, 2023 | 0.0464 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.042 |
| December 31, 2022 | 0.0387 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0387
Minimum
Dec 2022
0.0511
Maximum
Sep 2023
0.0456
Average
0.0464
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| Bruker Corp | 0.9305 |
| Azenta Inc | 0.00 |
| Harvard Bioscience Inc | 0.5004 |
| Bionano Genomics Inc | 0.7259 |
| Akoya Biosciences Inc | 1.400 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 265.47M |
| Total Liabilities (Quarterly) | 86.46M |
| Shareholders Equity (Quarterly) | 179.01M |
| Current Ratio | 10.51 |
| Net Debt Paydown Yield | 0.72% |